Dimethyl Fumarate Was Ineffective but Not Harmful for a Patient with Myelin Oligodendrocyte Glycoprotein Antibody Disease

We treated a myelin oligodendrocyte glycoprotein (MOG) antibody disease patient who had been prescribed dimethyl fumarate because she was thought to have been suffering from multiple sclerosis (MS). Mild optic neuritis relapsed at one year and four months after the administration of dimethyl fumarat...

Descripción completa

Detalles Bibliográficos
Autores principales: Warabi, Yoko, Takahashi, Toshiyuki, Isozaki, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886657/
https://www.ncbi.nlm.nih.gov/pubmed/31824807
http://dx.doi.org/10.7759/cureus.6040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886657/
https://www.ncbi.nlm.nih.gov/pubmed/31824807
http://dx.doi.org/10.7759/cureus.6040

Ejemplares similares